搜尋結果
Weight-loss drug Zepbound resolves sleep apnea in up to 52% of patients, Lilly says
Reuters· 2 小時前, opens new tab on Friday said its popular weight-loss drug Zepbound helped resolve moderate to ...
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of ...
CNBC· 2 小時前If cleared by the Food and Drug Administration, the company plans to launch Zepbound for ...
Desmarais-Backed Mortgage Firm Nesto Acquires Lender CMLS
Bloomberg· 2 小時前Nesto Inc., a Canadian online mortgage company backed by Montreal’s Desmarais family, struck a ...
U.S. jet fuel output rises to pre-COVID levels as demand soars
Reuters· 3 小時前U.S. refiners pumped out jet fuel last week at the fastest pace since the pandemic, government ...
US FDA approves Bristol Myers' colorectal cancer therapy
Reuters· 4 小時前... under the agency's accelerated process was based on an early- to mid-stage study, in w ...
Altria’s Menthol E-Cigs Get FDA Nod as Menthol Debate Continues
Bloomberg· 5 小時前Have a confidential tip for our reporters? The US Food and Drug Administration said Friday it’s ...
Cogs of fate turning for Taiwan secessionists: China Daily editorial
China Daily· 5 小時前In the latest move in support of the pro-independence forces in ...
Stocks making the biggest moves midday: Sarepta Therapeutics, Hertz Global, Asana and more
CNBC· 6 小時前Shares of the biopharma company surged 33% after the U.S. Food and Drug Administration approved ...
In a first, FDA authorizes flavored e-cigarettes from Altria's NJOY for sale in the US ...
Reuters· 6 小時前The U.S. Food and Drug Administration authorized four of Altria's menthol e-cigarettes for ...
US Moves Closer to Restricting Outbound Investment in China for Chips, AI Tech
Bloomberg· 6 小時前The Biden administration advanced plans to restrict investments by US individuals and companies ...